Renaissance Technologies’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $149K | Sell |
116,639
-108,615
| -48% | -$139K | ﹤0.01% | 3230 |
|
2025
Q1 | $225K | Buy |
225,254
+137,234
| +156% | +$137K | ﹤0.01% | 3044 |
|
2024
Q4 | $80.1K | Buy |
88,020
+8,400
| +11% | +$7.64K | ﹤0.01% | 3318 |
|
2024
Q3 | $119K | Buy |
79,620
+3,800
| +5% | +$5.7K | ﹤0.01% | 3229 |
|
2024
Q2 | $53.3K | Sell |
75,820
-3,800
| -5% | -$2.67K | ﹤0.01% | 3283 |
|
2024
Q1 | $76K | Sell |
79,620
-95,700
| -55% | -$91.3K | ﹤0.01% | 3417 |
|
2023
Q4 | $195K | Buy |
175,320
+56,220
| +47% | +$62.5K | ﹤0.01% | 3141 |
|
2023
Q3 | $224K | Buy |
119,100
+200
| +0.2% | +$376 | ﹤0.01% | 3048 |
|
2023
Q2 | $427K | Buy |
118,900
+300
| +0.3% | +$1.08K | ﹤0.01% | 2959 |
|
2023
Q1 | $400K | Buy |
118,600
+200
| +0.2% | +$675 | ﹤0.01% | 2992 |
|
2022
Q4 | $184K | Sell |
118,400
-79,396
| -40% | -$123K | ﹤0.01% | 3446 |
|
2022
Q3 | $269K | Buy |
197,796
+57,676
| +41% | +$78.4K | ﹤0.01% | 3256 |
|
2022
Q2 | $307K | Buy |
140,120
+55,220
| +65% | +$121K | ﹤0.01% | 3447 |
|
2022
Q1 | $271K | Buy |
+84,900
| New | +$271K | ﹤0.01% | 3514 |
|
2021
Q3 | – | Sell |
-140,100
| Closed | -$1.06M | – | 3531 |
|
2021
Q2 | $1.06M | Sell |
140,100
-39,900
| -22% | -$301K | ﹤0.01% | 2640 |
|
2021
Q1 | $1.56M | Buy |
180,000
+106,900
| +146% | +$928K | ﹤0.01% | 2379 |
|
2020
Q4 | $583K | Sell |
73,100
-22,900
| -24% | -$183K | ﹤0.01% | 2751 |
|
2020
Q3 | $766K | Buy |
+96,000
| New | +$766K | ﹤0.01% | 2644 |
|
2019
Q2 | – | Sell |
-38,800
| Closed | -$294K | – | 3571 |
|
2019
Q1 | $294K | Sell |
38,800
-82,900
| -68% | -$628K | ﹤0.01% | 3100 |
|
2018
Q4 | $983K | Buy |
+121,700
| New | +$983K | ﹤0.01% | 2577 |
|
2018
Q3 | – | Sell |
-230,300
| Closed | -$2.63M | – | 3372 |
|
2018
Q2 | $2.63M | Buy |
+230,300
| New | +$2.63M | ﹤0.01% | 2131 |
|